نتائج البحث - Jin‐Guang Yao

  • يعرض 1 - 6 نتائج من 6
تنقيح النتائج
  1. 1
    Recent advances in CD8+ regulatory T�cell research (Review)

    Recent advances in CD8+ regulatory T�cell research (Review) حسب Yating Yu, Xinbo Ma, Rufei Gong, Jianmeng Zhu, Lihua Wei, Jin‐Guang Yao

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis

    MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis حسب Xiao‐Ying Huang, Jin‐Guang Yao, Hongdong Huang, Chao Wang, Yun Ma, Qiang Xia, Xi‐Dai Long

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis

    MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis حسب Yixiao Liu, Xi‐Dai Long, Zhifeng Xi, Yun Ma, Xiao‐Ying Huang, Jin‐Guang Yao, Chao Wang, Tianyu Xing, Qiang Xia

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study

    Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled pha... حسب Marianne Pavel, Éric Baudin, Kjell E. Öberg, John D. Hainsworth, Maurizio Voi, Nicolas Rouyrre, Marc Peeters, David J. Gross, Jin‐Guang Yao

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Genetic Polymorphisms in DNA Repair Genes XRCC4 and XRCC5 and Aflatoxin B1–related Hepatocellular Carcinoma

    Genetic Polymorphisms in DNA Repair Genes XRCC4 and XRCC5 and Aflatoxin B1–related Hepatocellular Carcinoma حسب Xi‐Dai Long, Dong Zhao, Chao Wang, Xiao‐Ying Huang, Jin‐Guang Yao, Yun Ma, Zhonghua Wei, Min Liu, Lixiao Zeng, Xiaoqiang Mo, Jianjun Zhang, Feng Xue, Bo Zhai, Qiang Xia

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial

    A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrin... حسب Matthew H. Kulke, Philippe Ruszniewski, Eric Van Cutsem, Catherine Lombard‐Bohas, Juan W. Valle, Wouter W. de Herder, Marianne Pavel, Evgeny Degtyarev, Jan C. Brase, Lida Bubuteishvili‐Pacaud, Maurizio Voi, Ramón Salazar, Ivan Borbath, Nicola Fazio, Denis Smith, Jaume Capdevila, Rachel P. Riechelmann, Jin‐Guang Yao

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: